46 related articles for article (PubMed ID: 10415871)
1. The novel Trk receptor tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits antitumor efficacy against human pancreatic carcinoma (Panc1) xenograft growth and in vivo invasiveness.
Miknyoczki SJ; Dionne CA; Klein-Szanto AJ; Ruggeri BA
Ann N Y Acad Sci; 1999 Jun; 880():252-62. PubMed ID: 10415871
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpoint.
Collins C; Carducci MA; Eisenberger MA; Isaacs JT; Partin AW; Pili R; Sinibaldi VJ; Walczak JS; Denmeade SR
Cancer Biol Ther; 2007 Sep; 6(9):1360-7. PubMed ID: 17786033
[TBL] [Abstract][Full Text] [Related]
3. Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma.
Massó-Vallés D; Jauset T; Serrano E; Sodir NM; Pedersen K; Affara NI; Whitfield JR; Beaulieu ME; Evan GI; Elias L; Arribas J; Soucek L
Cancer Res; 2015 Apr; 75(8):1675-81. PubMed ID: 25878147
[TBL] [Abstract][Full Text] [Related]
4. Roles of the nervous system in pancreatic cancer.
Wakiya T; Ishido K; Yoshizawa T; Kanda T; Hakamada K
Ann Gastroenterol Surg; 2021 Sep; 5(5):623-633. PubMed ID: 34585047
[TBL] [Abstract][Full Text] [Related]
5. Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer.
Caban M; Małecka-Wojciesko E
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067280
[TBL] [Abstract][Full Text] [Related]
6. Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemia.
Ezelarab HAA; Ali TFS; Abbas SH; Hassan HA; Beshr EAM
BMC Chem; 2023 Jul; 17(1):73. PubMed ID: 37438819
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors.
Singha M; Pu L; Stanfield BA; Uche IK; Rider PJF; Kousoulas KG; Ramanujam J; Brylinski M
BMC Cancer; 2022 Nov; 22(1):1211. PubMed ID: 36434556
[TBL] [Abstract][Full Text] [Related]
8. FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms.
Acharya B; Saha D; Armstrong D; Lakkaniga NR; Frett B
RSC Med Chem; 2022 Jul; 13(7):798-816. PubMed ID: 35923716
[TBL] [Abstract][Full Text] [Related]
9. Blood Vessels and Peripheral Nerves as Key Players in Cancer Progression and Therapy Resistance.
Roda N; Blandano G; Pelicci PG
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503281
[TBL] [Abstract][Full Text] [Related]
10. Mouse Nerve Growth Factor Facilitates the Growth of Interspinal Schwannoma Cells by Activating NGF Receptors.
Liu SY; Liu SZ; Li Y; Chen S
J Korean Neurosurg Soc; 2019 Nov; 62(6):626-634. PubMed ID: 31527385
[TBL] [Abstract][Full Text] [Related]
11. A neuroprotective agent that inactivates prodegenerative TrkA and preserves mitochondria.
Feinberg K; Kolaj A; Wu C; Grinshtein N; Krieger JR; Moran MF; Rubin LL; Miller FD; Kaplan DR
J Cell Biol; 2017 Nov; 216(11):3655-3675. PubMed ID: 28877995
[TBL] [Abstract][Full Text] [Related]
12. Neurogenin 3 is regulated by neurotrophic tyrosine kinase receptor type 2 (TRKB) signaling in the adult human exocrine pancreas.
Shamblott MJ; O'Driscoll ML; Gomez DL; McGuire DL
Cell Commun Signal; 2016 Sep; 14(1):23. PubMed ID: 27659207
[TBL] [Abstract][Full Text] [Related]
13. Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer.
Akil H; Perraud A; Jauberteau MO; Mathonnet M
World J Gastroenterol; 2016 Jan; 22(2):490-500. PubMed ID: 26811602
[TBL] [Abstract][Full Text] [Related]
14. TrkB Promotes Breast Cancer Metastasis via Suppression of Runx3 and Keap1 Expression.
Kim MS; Lee WS; Jin W
Mol Cells; 2016 Mar; 39(3):258-65. PubMed ID: 26657794
[TBL] [Abstract][Full Text] [Related]
15. TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.
Croucher JL; Iyer R; Li N; Molteni V; Loren J; Gordon WP; Tuntland T; Liu B; Brodeur GM
Cancer Chemother Pharmacol; 2015 Jan; 75(1):131-41. PubMed ID: 25394774
[TBL] [Abstract][Full Text] [Related]
16. Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).
Nannini M; Astolfi A; Urbini M; Indio V; Santini D; Heinrich MC; Corless CL; Ceccarelli C; Saponara M; Mandrioli A; Lolli C; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Cancer; 2014 Sep; 14():685. PubMed ID: 25239601
[TBL] [Abstract][Full Text] [Related]
17. AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.
Iyer R; Varela CR; Minturn JE; Ho R; Simpson AM; Light JE; Evans AE; Zhao H; Thress K; Brown JL; Brodeur GM
Cancer Chemother Pharmacol; 2012 Sep; 70(3):477-86. PubMed ID: 22623209
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.
Norris RE; Minturn JE; Brodeur GM; Maris JM; Adamson PC
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1469-75. PubMed ID: 21484309
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.
Minturn JE; Evans AE; Villablanca JG; Yanik GA; Park JR; Shusterman S; Groshen S; Hellriegel ET; Bensen-Kennedy D; Matthay KK; Brodeur GM; Maris JM
Cancer Chemother Pharmacol; 2011 Oct; 68(4):1057-65. PubMed ID: 21340605
[TBL] [Abstract][Full Text] [Related]
20. K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.
Ng YK; Wong EY; Lau CP; Chan JP; Wong SC; Chan AS; Kwan MP; Tsao SW; Tsang CM; Lai PB; Chan AT; Lui VW
Invest New Drugs; 2012 Feb; 30(1):48-58. PubMed ID: 20694504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
